Bayer starts hybrids cheap, cranks in hard
Germany’s Bayer took a cautious approach to issuing a €1.75bn dual tranche hybrid capital issue on Thursday, but despite the huge litigation battle it is facing, yield-hungry investors piled into the deal, pushing the book above €10bn and enabling Bayer to chop a fat slice off the yields.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts